Mylan Announces Tentative FDA Approval for Topiramate Capsules

Mylan Laboratories Inc. announced that Mylan Pharmaceuticals Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for Topiramate Capsules, 15 mg and 25 mg.
Mylan